Perceptions of overdetection of breast cancer among women 70 years of age and older in the USA: a mixed-methods analysis

Abstract

ObjectivesCurrent research on the perceptions of overdiagnosis or overdetection of breast cancer has largely been conducted outside of the USA and with women younger than 70 years.Therefore, we explored older women’s perceptions about the concept of overdetection of breast cancer and its influence on future screening intentions.DesignMixed-methods analysis using purposive sampling based on race/ethnicity, age and educational level. Semistructured interviews, including two hypothetical scenarios illustrating benefits and harms of screening and overdetection, were analysed using inductive and deductive thematic approaches. An inferential clustering technique was used to assess overall patterns in narrative content by sociodemographic characteristics, personal screening preferences or understanding of overdetection.SettingHouston/Galveston, Texas, USA.Participants59 English-speaking women aged 70 years and older with no prior history of breast cancer.ResultsVery few women were familiar with the concept of overdetection and overtreatment. After the scenarios were presented, half of the women still demonstrated a lack of understanding of the concept of overdetection. Many women expressed suspicion of the concept, equating it to rationing. Women who showed understanding of overdetection were more likely to express an intent to discontinue screening, although 86% of the women stated that hearing about overdetection did not influence their screening decision. Themes identified did not differ by race/ethnicity, education, age or screening preferences. Differences were identified between women who understood overdetection and women who did not (r=0.23, p<0.001).ConclusionsMany older women did not understand the concept of overdetection, in addition to being suspicious of or resistant to the concept. Providing older women with descriptions of overdetection may not be sufficient to influence screening intentions.

A Review of the Presentation of Overdiagnosis in Cancer Screening Patient Decision Aids

“…Evidence shows that there is poor lay understanding of these concepts in the context of cancer screening and descriptions such as ''unnecessary diagnosis'' or ''diagnosis of a condition that would never have caused harm'' may be a better method to explain overdiagnosis. 37,49 Avoiding the use of the specific terms ''overdiagnosis'' and ''overtreatment'' may be purposeful. By describing these concepts rather than using the specific terms, PDA developers may be able to create aids with plain language communication and designed for the cultural context that may assist patients as they work to understand concepts related to overdiagnosis.…”

Women’s Acceptance of Overdetection in Breast Cancer Screening: Can We Assess Harm-Benefit Tradeoffs?

“…Qualitative studies have assessed women’s views on overdetection, showing that women are often surprised or even upset when they hear about it. 9,10 Studies that assessed acceptance of overdiagnosis quantitatively have shown widely varying ratios, for example, from 50% accepting at maximum a 1:1 ratio when starting screening, to 60% of previous screeners accepting a 1:10 ratio. 11 Van den Bruel et al 12 added a limited description of the consequences of overdetection in terms of treatments that patients would undergo following diagnosis.…”

Resistance to discontinuing breast cancer screening in older women: A qualitative study

“…In a separate analysis of these participants, Hoover and colleagues found that older women wanted the opportunity to hear about the benefits and harms of breast cancer screening from their physician or another health care provider . Additionally, Pappadis et al found that older women demonstrated a limited understanding of the downsides associated with continued screening, like overdiagnosis Our findings build on this prior work and highlight the role of physicians in screening decision making. Even though women intended to continue screening, they were willing to discuss breast cancer screening discontinuation in the 2 doctor's recommendation scenarios.…”